January 1, 2021 – Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH

article-01-01-2021

Please CLICK HERE to read the article, “Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH“

/ Uncategorized
  • Next Post
  • Previous Post
SIGN UP NOW

Click here to participate in a study

NRI CLINICS ARE CURRENTLY OPEN!
COVID-19 Information
X